{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:33:20Z","timestamp":1744209200109},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T00:00:00Z","timestamp":1649376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Data on outcome of patients with mantle cell lymphoma (MCL) and COVID-19 infection are limited. The European MCL (EMCL) registry is a centralized registry of the EMCL network, collecting real-world information about treatments and disease courses. During the COVID-19 pandemic, additional data on MCL patients with COVID-19 infection were collected, aiming to identify risk factors for mortality from COVID-19. In our retrospective, multicenter, international study, we collected data from 63 MCL patients with a median age of 64 years (range, 44\u201384) in 9 countries with evidence of a COVID-19 infection between February 2020 and October 2021. The overall mortality rate was high (44.4%), especially in hospitalized patients (61%) and in patients with need for intensive care unit care (94%). Patients receiving rituximab had significantly poorer survival than patients not receiving rituximab (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.04). Our data highlight the importance of prevention strategies and underline the need for effective vaccination in this vulnerable cohort.<\/jats:p>","DOI":"10.1097\/hs9.0000000000000711","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T14:10:01Z","timestamp":1649427001000},"page":"e0711","source":"Crossref","is-referenced-by-count":10,"title":["Outcome of COVID-19 in Patients With Mantle Cell Lymphoma\u2014Report From the European MCL Registry"],"prefix":"10.1002","volume":"6","author":[{"given":"Marie-Kristin","family":"Tilch","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology and Pneumology & University Cancer Center, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology, University of Verona, Verona, Italy"}]},{"given":"Sandra","family":"Kinda","sequence":"additional","affiliation":[{"name":"University Hospital Center Zagreb, Department of Internal Medicine, Division of Hematology, Zagreb, Croatia"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Department of Hematology, H\u00f4pital Necker, Assistance Publique\u2014H\u00f4pitaux de Paris, France"}]},{"given":"Milena","family":"Kohn","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France; Universit\u00e9 Versailles Saint Quentin en Yvelines, Universit\u00e9 Paris-Saclay, Montigny le Bretonneux, France"}]},{"given":"Caroline","family":"Besson","sequence":"additional","affiliation":[{"name":"Service d\u2019H\u00e9matologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, France; Universit\u00e9 Versailles Saint Quentin en Yvelines, Universit\u00e9 Paris-Saclay, Montigny le Bretonneux, France"}]},{"given":"Sylvain","family":"Lamure","sequence":"additional","affiliation":[{"name":"Departement d\u2019H\u00e9matologie Clinique, CHU de Montpellier, UMR-CNRS 5535, Universit\u00e9 de Montpellier, France"}]},{"given":"R\u00e9my","family":"Dul\u00e9ry","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM UMRs938, Service d\u2019H\u00e9matologie Clinique et de Th\u00e9rapie Cellulaire, H\u00f4pital Saint Antoine, AP-HP, Paris, France"}]},{"given":"Simone","family":"Ragaini","sequence":"additional","affiliation":[{"name":"Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino\/\u201cCitt\u00e0 della Salute e della Scienza di Torino\u201d University Hospital, Turin, Italy"}]},{"given":"Toby A.","family":"Eyre","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology, Oxford Cancer and Hematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom"}]},{"given":"Tom","family":"Van Meerten","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Groningen, University Medical Center Groningen, Netherlands"}]},{"given":"Anke","family":"Ohler","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Pneumology & University Cancer Center, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany"}]},{"given":"Steffen","family":"Eckerle","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Pneumology & University Cancer Center, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany"}]},{"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[{"name":"Department of Medicine III, LMU Hospital, Munich, Germany"}]},{"given":"Georg","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Pneumology & University Cancer Center, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany"}]},{"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain"}]},{"given":"Maria","family":"Gomes da Silva","sequence":"additional","affiliation":[{"name":"Department of Hematology, Instituto Portugu\u00eas de Oncologia de Lisboa, Portugal"}]}],"member":"311","published-online":{"date-parts":[[2022,5]]},"reference":[{"key":"R1-20231125","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project.","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"R2-20231125","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"R3-20231125","doi-asserted-by":"crossref","first-page":"112516","DOI":"10.18632\/oncotarget.22367","article-title":"Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: a comparative study between Texas and National SEER areas.","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"R4-20231125","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1200\/JCO.20.02287","article-title":"High-risk mantle cell lymphoma: definition, current challenges, and management.","volume":"38","author":"Jain","year":"2020","journal-title":"J Clin Oncol"},{"key":"R5-20231125","doi-asserted-by":"crossref","first-page":"iv62","DOI":"10.1093\/annonc\/mdx223","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"28","author":"Dreyling","year":"2017","journal-title":"Annals Oncol"},{"key":"R6-20231125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(16)00739-X","article-title":"Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.","volume":"388","author":"Hermine","year":"2016","journal-title":"Lancet"},{"key":"R7-20231125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1200920","article-title":"Treatment of older patients with mantle-cell lymphoma.","volume":"367","author":"Kluin-Nelemans","year":"2012","journal-title":"N Engl J Med"},{"key":"R8-20231125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"R9-20231125","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1182\/bloodadvances.2020004074","article-title":"Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.","volume":"5","author":"Tam","year":"2021","journal-title":"Blood Adv"},{"key":"R10-20231125","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood.2019852368","article-title":"Acalabrutinib for mantle cell lymphoma.","volume":"133","author":"Witzig","year":"2019","journal-title":"Blood"},{"key":"R11-20231125","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.3324\/haematol.2018.198812","article-title":"Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy.","volume":"104","author":"Eyre","year":"2019","journal-title":"Haematologica"},{"key":"R12-20231125","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma.","volume":"382","author":"Wang","year":"2020","journal-title":"N Engl J Med"},{"key":"R13-20231125","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41375-019-0388-x","article-title":"Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL).","volume":"33","author":"Maschmeyer","year":"2019","journal-title":"Leukemia"},{"key":"R14-20231125","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019.","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"R15-20231125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejca.2020.08.011","article-title":"Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies.","volume":"139","author":"Saini","year":"2020","journal-title":"Eur J Cancer"},{"key":"R16-20231125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/GO.20.00225","article-title":"Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data.","volume":"6","author":"Giannakoulis","year":"2020","journal-title":"JCO Glob Oncol"},{"key":"R17-20231125","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.21.01074","article-title":"Outcomes of COVID-19 in patients with cancer: report from the national covid cohort collaborative (N3C).","volume":"39","author":"Sharafeldin","year":"2021","journal-title":"J Clin Oncol"},{"key":"R18-20231125","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience.","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"key":"R19-20231125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41586-020-2918-0","article-title":"Age-specific mortality and immunity patterns of SARS-CoV-2.","volume":"590","author":"O\u2019Driscoll","year":"2021","journal-title":"Nature"},{"key":"R20-20231125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5501\/wjv.v10.i6.312","article-title":"COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review.","volume":"10","author":"Bonuomo","year":"2021","journal-title":"World J Virol"},{"key":"R21-20231125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/0284186X.2020.1837946","article-title":"Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.","volume":"60","author":"Park","year":"2021","journal-title":"Acta Oncol"},{"issue":"Supplement 1","key":"R22-20231125","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1182\/blood-2021-149652","article-title":"COVID-19 vaccine response in patients with hematologic malignancy: a systematic review and meta-analysis.","volume":"138","author":"Gong","year":"2021","journal-title":"Blood"},{"key":"R23-20231125","doi-asserted-by":"crossref","first-page":"759108","DOI":"10.3389\/fonc.2021.759108","article-title":"Antibody responses to COVID-19 vaccination in cancer: a systematic review.","volume":"11","author":"Guven","year":"2021","journal-title":"Front Oncol"},{"key":"R24-20231125","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.eclinm.2020.100549","article-title":"Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study.","volume":"27","author":"Lamure","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R25-20231125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.26209","article-title":"Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.","volume":"96","author":"Dul\u00e9ry","year":"2021","journal-title":"Am J Hematol"},{"key":"R26-20231125","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1097\/HS9.0000000000000538","article-title":"Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study.","volume":"5","author":"Regalado-Artamendi","year":"2021","journal-title":"HemaSphere"},{"key":"R27-20231125","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.annonc.2021.02.024","article-title":"Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.","volume":"32","author":"Grivas","year":"2021","journal-title":"Ann Oncol"},{"key":"R28-20231125","doi-asserted-by":"crossref","first-page":"102525","DOI":"10.1016\/j.bcmd.2020.102525","article-title":"Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.","volume":"87","author":"Borah","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"R29-20231125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2021005691","article-title":"A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study.","volume":"6","author":"Visco","year":"2021","journal-title":"Blood Adv"},{"key":"R30-20231125","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1038\/s41375-021-01450-8","article-title":"COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.","volume":"35","author":"Chatzikonstantinou","year":"2021","journal-title":"Leukemia"},{"key":"R31-20231125","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jmv.26404","article-title":"The outcome of COVID-19 in patients with hematological malignancy.","volume":"93","author":"Yigenoglu","year":"2021","journal-title":"J Med Virol"},{"key":"R32-20231125","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1182\/blood.V124.21.2526.2526","article-title":"High dose therapy and autologous stem cell transplantation in marginal zone lymphoma: an EBMT-FIL-gimeto retrospective study.","volume":"124","author":"Avivi","year":"2014","journal-title":"Blood"},{"key":"R33-20231125","doi-asserted-by":"crossref","first-page":"e1003773","DOI":"10.1371\/journal.pmed.1003773","article-title":"Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.","volume":"18","author":"Taquet","year":"2021","journal-title":"PLoS Med"}],"container-title":["HemaSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HS9.0000000000000711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T18:08:35Z","timestamp":1702922915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HS9.0000000000000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,8]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/hs9.0000000000000711","relation":{},"ISSN":["2572-9241"],"issn-type":[{"value":"2572-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,8]]}}}